Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 10:06 PM ET

Diversified Consumer Services

Company Overview of University of Cambridge

Company Overview

University of Cambridge is an educational institution that offers graduate, postgraduate, and research programs in the field of science, business, social sciences, and law. It offers courses in history, environmental studies, psychology, sociology, zoology, oriental studies, business administration, philosophy, biochemistry, music, engineering, geology, architecture, international relations, and medicine. The institution was founded in 1209 and is based in Cambridge, United Kingdom.

The Old Schools

Trinity Lane

Cambridge,  CB2 1TN

United Kingdom

Founded in 1209

Phone:

44 1223 332290

Fax:

44 1223 339669

Key Executives for University of Cambridge

Vice Chancellor
Regius Professor of Physic
Master of Pembroke College
Age: 70
Head of Institute for Stem Cell Biology
Compensation as of Fiscal Year 2015.

University of Cambridge Key Developments

DefiniGEN Announces Licensing Agreement with University of Cambridge

DefiniGEN Ltd. has licensed lung stem cell technology from University of Cambridge. DefiniGEN will use the technology to develop cell products and services for drug discovery and the study of lung diseases, including cystic fibrosis.

University of Cambridge Presents at Credit Suisse 6th Annual European Pensions Strategy Conference, Apr-23-2015 09:30 AM

University of Cambridge Presents at Credit Suisse 6th Annual European Pensions Strategy Conference, Apr-23-2015 09:30 AM. Venue: Credit Suisse, 20 Columbus Courtyard, Canary Wharf, London E14 4DA, United Kingdom. Speakers: Elroy Dimson.

H. Lundbeck A/S Announces Research Partnership for Treatment of Brain Diseases Involving Seven Universities

H. Lundbeck A/S has announced a new public-private partnership involving seven universities, for the treatment of brain diseases. Lundbeck is involved in new research that will investigate a novel link that could show a relationship between the immune system and mood disorders, such as depression, and neurodegenerative diseases, such as Alzheimer's disease. This project, a public-private partnership also involving The Wellcome Trust, Cambridge University and pharmaceutical company Janssen, may be the first step towards a new and significantly improved treatment for a broad range of brain diseases. The main theory that the project will investigate is that the immune system can worsen brain diseases like depression and Alzheimer's disease. An imbalance in the immune system of the brain can drive a permanent and unhealthy neuro-inflammation - or inflammation in the brain - that can contribute to or cause brain diseases. This new project is a public-private partnership between Lundbeck and Janssen, and seven universities. The project has received a strategic award valued at approximately DKK 50m from the Wellcome Trust. The project consists of two parts. The team will begin by investigating the immune systems of people with treatment-resistant depression and Alzheimer's disease. In this phase, researchers will seek to more precisely establish the relationship between immune-related biomarkers found in blood and brain including cytokines, which are small proteins that play an important role in the regulation of the immune responses. The second part of the research program, which is reliant on the success of the first, will focus on small experimental medicine trials, using re-purposed anti-inflammatory drugs in patients who have been identified according to their specific immunological profile or 'phenotype'.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact University of Cambridge, please visit www.cam.ac.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.